Yeah for the FDA!

Posted on May 29, 2012


It isn’t often that we get a chance to cheer for an agency that does outstanding work but here is one for the FDA.  The New England Journal of Medicine did a study supported by the Pew Foundation and found that the FDA approved drugs faster than the agencies with that responsibility in Canada and Europe.  Congratulations for the great work.

On May 16th the New England Journal of Medicine released a new report showing that the FDA actually had significantly faster approval times for new drugs than similar regulatory agencies in Canada and in Europe. The FDA is frequently criticized publicly for being too slow in approving new medicines. A copy of the report can be found here.

In conclusion, we found that among novel therapeutics approved between 2001 and 2010, the FDA reviewed applications more quickly, on average, than did the EMA and Health Canada, and the vast majority of these novel therapeutics were first approved for use in the United States. Our findings contradict recent criticisms of the speed of review by the FDA and lead to questions about whether the speed of the review process is justified as an emphasis for PDUFA V, particularly since the FDA continues to outpace its European and Canadian peers.

Posted in: Healthy Living